Ruifen Dong

Nanjing University of Science and Technology — China

Biochemistry, Genetics and Molecular Biology · Life Sciences

16h-index864citations34works2.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer-related molecular mechanisms research(10), MicroRNA in disease regulation(9), Ovarian cancer diagnosis and treatment(6), Endometrial and Cervical Cancer Treatments(6), Epigenetics and DNA Methylation(5)

Publications34 total

Development and validation of a prediction model for lymph node metastasis based on molecular typing in clinically early-stage endometrial carcinoma
Journal of Gynecologic Oncology·2025Open Access
Molecular subtyping of endometrial cancer via a simplified one-step NGS classifier, ARID1A and ZFHX4 mutations help further subclassify CNL/MSI-H patients
Diagnostic Pathology·2025· 2 citedOpen Access
Risk of Cervical Carcinoma After Unfavorable Behavior and High Genetic Risk in the UK Biobank: A Prospective Nested Case–Control Study
Biomedicines·2025Open Access
Comparative Study of the Tensile Properties of a Zircaloy-4 Alloy Characterized by Mesoscale and Standard Specimens
Materials·2025Open Access
Establishment and verification of a prognostic signature associated with fatty acid metabolism in endometrial cancer
Molecular Medicine Reports·2025· 2 citedOpen Access
Blockade of the lncRNA-PART1-PHB2 axis confers resistance to PARP inhibitor and promotes cellular senescence in ovarian cancer
Cancer Letters·2024· 15 citedOpen Access
Development and validation of a prediction model for lymph node metastasis based on molecular classification in endometrial carcinoma.
Journal of Clinical Oncology·2024
Table of Contents
Journal of Lightwave Technology·2024Open Access
Supplementary Figures 1 - 5, Table 1 from <i>miR-106a</i> Represses the Rb Tumor Suppressor p130 to Regulate Cellular Proliferation and Differentiation in High-Grade Serous Ovarian Carcinoma
2023Open Access
Data from <i>miR-106a</i> Represses the Rb Tumor Suppressor p130 to Regulate Cellular Proliferation and Differentiation in High-Grade Serous Ovarian Carcinoma
2023Open Access
Supplementary Figures 1 - 5, Table 1 from <i>miR-106a</i> Represses the Rb Tumor Suppressor p130 to Regulate Cellular Proliferation and Differentiation in High-Grade Serous Ovarian Carcinoma
2023Open Access
Data from <i>miR-106a</i> Represses the Rb Tumor Suppressor p130 to Regulate Cellular Proliferation and Differentiation in High-Grade Serous Ovarian Carcinoma
2023Open Access
Upregulated MELK Leads to Doxorubicin Chemoresistance and M2 Macrophage Polarization via the miR-34a/JAK2/STAT3 Pathway in Uterine Leiomyosarcoma
Frontiers in Oncology·2020· 43 citedOpen Access
MiR-509-3 augments the synthetic lethality of PARPi by regulating HR repair in PDX model of HGSOC
Journal of Hematology & Oncology·2020· 31 citedOpen Access
Additional file 6 of MiR-509-3 augments the synthetic lethality of PARPi by regulating HR repair in PDX model of HGSOC
Figshare·2020Open Access
Additional file 8 of MiR-509-3 augments the synthetic lethality of PARPi by regulating HR repair in PDX model of HGSOC
Figshare·2020Open Access
Additional file 10 of MiR-509-3 augments the synthetic lethality of PARPi by regulating HR repair in PDX model of HGSOC
Figshare·2020Open Access
Squamous cell carcinoma transformation in mature cystic teratoma of the ovary: a systematic review
BMC Cancer·2019· 90 citedOpen Access
Anti-angiogenesis effect of Neferine via regulating autophagy and polarization of tumor-associated macrophages in high-grade serous ovarian carcinoma
Cancer Letters·2018· 46 cited
miR-130a upregulates mTOR pathway by targeting TSC1 and is transactivated by NF-κB in high-grade serous ovarian carcinoma
Cell Death and Differentiation·2017· 71 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Zhaojian Liu(12), Beihua Kong(11), Beihua Kong(9), Changshun Shao(8), Xiyu Zhang(7), Kun Song(7), Qifeng Yang(6), Jinsong Liu(6), Xingsheng Yang(6), Beihua Kong(6), Jian-Jun Wei(5), Chenggong Sun(5), Elizabeth Gersbach(5), Xiaofei Xu(5), Peng Lee(5), Samina Dongol(5), Yinuo Li(4), Qing Zhang(4), Qing Zhang(4), Wenyu Cao(4)